How about a 50% gain in one week? That's the worst performance among these health-care high flyers.
The details behind Roche's deal with Pacific Biosciences of California.
Is Pacific Biosciences' new arrangement with Roche a good deal? Mr. Market gives PacBio's deal a big thumbs up.
Covance is doing well with its contract research business.
Two important things you need to know about the future of Illumina.
Are these three stocks sells or belles? You be the judge!
Exact Sciences' roller coaster ride is now on a huge upswing. Time to buy -- or sell?
Do short-sellers have these stocks pegged? You be the judge!
Market-trouncing returns could be written in this 5-star stock.
Let's see what the numbers say about Sequenom (SQNM).